Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
BioMarin Pharmaceutical
ISIN US09061G1013
|WKN 924801
Market cap (in EUR)
9,833 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Quote
Description
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Graphique
Données financières
Indicateurs clés
| Capitalisation boursière, EUR | 9,833 m |
| BPA, EUR | 1.58 |
| Ratio cours/valeur comptable | 1.8 |
| PER | 32.4 |
| Rendement en dividendes | 0.00% |
Income statement (2025)
| Chiffre d'affaires, EUR | 2,874 m |
| Résultat net, EUR | 309 m |
| Marge bénéficiaire | 10.76% |
What ETF is BioMarin Pharmaceutical in?
There are 13 ETFs which contain BioMarin Pharmaceutical. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioMarin Pharmaceutical is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
Rendement
Aperçu des rendements
| Année en cours | -1,77% |
| 1 mois | -0,71% |
| 3 mois | +13,53% |
| 6 mois | +9,99% |
| 1 an | -21,68% |
| 3 ans | -43,17% |
| 5 ans | -22,85% |
| Depuis la création (MAX) | -40,66% |
| 2025 | -19,79% |
| 2024 | -27,75% |
| 2023 | -8,14% |
| 2022 | +20,96% |
Rendements mensuels dans une heat map
Risque
Les rendements des ETF comprennent les paiements de dividendes (le cas échéant).
Aperçu des risques
| Volatilité 1 an | 37,65% |
| Volatilité 3 ans | 32,58% |
| Volatilité 5 ans | 31,79% |
| Rendement par risque 1 an | -0,58 |
| Rendement par risque 3 ans | -0,53 |
| Rendement par risque 5 ans | -0,16 |
| Perte maximale sur 1 an | -34,70% |
| Perte maximale sur 3 ans | -51,92% |
| Perte maximale sur 5 ans | -59,31% |
| Perte maximale depuis la création | -68,14% |
Volatilité sur 1 an
Articles les plus récents
Articles les plus consultés
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.